GSK starts 2020 on a high, but warns of tougher times ahead

Shingrix and Trelegy shield GSK from Advair fallout

Shingles vaccine boosts GSK as generic Advair bites

GSK’s first quarter sales beat estimates, helped along by shingles vaccine Shingrix and partly offsetting the effect of declining Advair sales.

FDA approval gained, Glaxo awaits key committee blessing for...

The FDA granted approval to GSK's new shingles vaccine Shingrix on Friday, giving the company the green light on one of its important new products.

Tipped to hit $1bn, GSK’s Shingrix gains committee approval

GlaxoSmithKline’s shingles vaccine Shingrix has gained the unanimous backing of an FDA advisory committee.